45. On September 12, 2017, Inotek Pharmaceuticals agreed to acquire Rocket Pharmaceuticals, Ltd., a privately held biopharmaceutical
Question:
45. On September 12, 2017, Inotek Pharmaceuticals agreed to acquire Rocket Pharmaceuticals, Ltd., a privately held biopharmaceutical company in a taxdeferred acquisition. Form 8-K for Inotek (NASDAQ ticker ITEK, cik 0001281895) describes the transaction and was filed with the SEC on August 13, 2012. You can access Form 8-K at the SEC’s Investor website:
(https://www.sec.gov/Archives/edgar/data/12818 95/000119312517283239/d421363d8k.htm). Read
“Item 1.01, Entry into a Material Definitive Agreement” and determine which form of merger was used to effect the acquisition.
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Taxation Of Individuals And Business Entities 2020
ISBN: 9781259969614
11th Edition
Authors: Brian Spilker, Benjamin Ayers, John Robinson, Edmund Outslay, Ronald Worsham, John Barrick, Connie Weaver
Question Posted: